This study is looking at whether a daily low dose of aspirin (81 mg) can help women who have had preeclampsia after giving birth. Preeclampsia is a serious condition during pregnancy that causes high blood pressure and can affect organs. Researchers want to see if aspirin can lower certain levels in your blood called Activin A, which are often high in women with preeclampsia. They also want to see if aspirin improves heart function (measured by something called GLS percentages). You could be eligible if you are a pregnant woman between 18 and 45 years old, diagnosed with preeclampsia, and are expecting one baby. The study aims to enroll about 180 participants. The current status of the study is unclear, meaning it might not be actively recruiting right now.

Study design

This is a single-center study where participants are randomly assigned to receive either aspirin or a placebo (an inactive pill) without knowing which they are getting. It is designed to compare the effects of these treatments.

What's involved

If you join, you would take a daily pill (either aspirin or placebo) starting at your first visit and continuing for up to 6 months. You would also have two blood draws: one when you are admitted for delivery and another at your 6-month postpartum visit.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 6 months after starting the study treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.